Lahey Hospital & Medical Center’s Cardiovascular Medicine Department has embraced using interventional cardiology to treat ...

A national study led by investigators from Cedars-Sinai Health Sciences University found that transcatheter tricuspid valve ...

The FDA has approved the NEXUS Aortic Arch Stent Graft enabling commercial launch of the NEXUS System in the US.

Endospan, a privately-held company pioneering solutions for the endovascular repair of aortic arch disease, today announced that the U.S. Food and Drug Administration (FDA) has approved the NEXUS (R) ...

Endospan, an Israel-based developer of solutions for the endovascular repair of aortic arch disease, announced that the FDA ...

The researchers identified a driving force behind the condition, opening up a potential target for new therapies.

Acute type A aortic dissection (ATAAD) is a life-threatening cardiovascular emergency where delays in diagnosis worsen outcomes. While computed tomography angiography remains the diagnostic gold ...

Abstract: The bicuspid aortic valve (BAV) is the most prevalent congen-ital heart defect and may require surgery for complications such as stenosis, regurgitation, and aortopathy. BAV repair surgery ...

The ALIGN-AR (TAVR With JenaValve for Symptomatic Aortic Regurgitation in High Surgical Risk Patients) trial findings demonstrated that, among patients with symptomatic moderate-to-severe or severe ...

The first in-human procedures were successfully performed at Massachusetts General Hospital in Boston and Jefferson University Hospital in Philadelphia by internationally recognised leaders in aortic ...

Aortic aneurysm and dissection (AAD) are life-threatening conditions characterized by progressive aortic dilation and acute aortic complications. Despite advances in surgical and endovascular ...

Please provide your email address to receive an email when new articles are posted on . Early surgery for very severe aortic stenosis reduced mortality vs. conservative care in asymptomatic patients.